The European Union drug regulator said Wednesday that it found a "possible link" between the AstraZeneca coronavirus vaccine and a rare clotting disorder but declined to impose any new age restrictions, saying the benefits of the shot still outweigh risks. Its U.K. counterpart, however, said it would offer people under 30 the choice of another product.
